Our thorough RNA‐seq analyses conducted on more than 260,000 cells across various breast cancer subtypes demonstrated that LARP6 expression is notably increased in TNBC compared to ER+ and HER2+ variants, highlighting LARP6 as a potential key regulator of TNBC progression. This evidence concerns the gene LARP6 and breast carcinoma.